Reproductive Endocrinology Luteal Phase

Early pregnancy wastage: the role of repetitive human chorionic gonadotropin supplementation during the first 8 weeks of gestation

Blumenfeld Z, Ruach M

Published July 1992 Fertility and Sterility, 58(1), 19-23
DOI 10.1016/s0015-0282(16)55130-9 PMID 1624004

RRM Academy Synopsis

Women given hCG in early pregnancy miscarried less often than controls

Miscarriage ended about 2 in 10 hCG-treated pregnancies and 5 in 10 untreated ones. This 1992 Israeli trial followed 447 pregnancies in infertile women at high risk. Assignment was partly randomized.

Pregnancies ending in miscarriage: Given hCG, 17.3 in 100; No hCG, 49 in 100
Pregnancies ending in miscarriage: Given hCG, 17.3 in 100; No hCG, 49 in 100. Source: Blumenfeld Z et al., 1992, PMID 1624004.
Study at a glance, partly randomized: Women given hCG in early pregnancy miscarried less often than controls
Study at a glance, partly randomized of 447 pregnancies: Women given hCG in early pregnancy miscarried less often than controls. Source: Blumenfeld Z et al., 1992, PMID 1624004.

Key Findings

  • Miscarriage ended 43 of 249 pregnancies given hCG (17.3%) and 97 of 198 in the control group (49%), P < 0.01.
  • After hMG/hCG ovulation induction, 20 of 94 pregnancies with hCG (21.3%) and 28 of 66 without (42.4%) ended in miscarriage, P < 0.05.
  • After clomiphene citrate ovulation induction, 15 of 95 pregnancies with hCG (15.8%) and 22 of 49 without (44.8%) ended in miscarriage, P < 0.01.
  • Among 143 spontaneous pregnancies in women with previous repeated abortions, 8 of 60 with hCG (13.3%) and 47 of 83 without (56.6%) ended in miscarriage, P < 0.001.
  • Seventy-nine of the 447 pregnancies (18%) were in groups the women chose themselves. Their miscarriage rates showed no significant difference from the randomized groups.

Interpretation

This study followed 447 pregnancies in infertile women at high risk for miscarriage. The women were grouped by risk. The authors presumed luteal dysfunction was the common cause behind giving hCG. The findings cover women after hMG/hCG or clomiphene citrate ovulation induction and women with previous repeated miscarriage. The authors note that their explanations for how hCG works remain theoretical and await validation. The findings support larger studies of this approach.

RRM Context

A restorative evaluation checks luteal function in each woman before treatment. Cycle charting can document the luteal phase. NaProTechnology, for example, defines luteal phase defects by charted criteria.

Abstract

Objective

To determine if repetitive administration of hCG causes decreased pregnancy wastage rates in patients who are at a high risk of luteal inadequacy.

Design

Ovulation induction using human menopausal gonadotropin (hMG)/human chorionic gonadotropin (hCG) or clomiphene citrate (CC) is associated with luteal phase defects that may cause increased pregnancy wastage. An increased risk of abortion exists also in pregnancies in patients with previous repeated miscarriage, women older than 37 years, and various causes of infertility such as hyperprolactinemia. Because the presumed common denominator to the increased rate of pregnancy wastage in all these cases is luteal dysfunction, repetitive hCG administration, 2,500 U two times weekly, was carried out between the 4th and 8th week of gestation in 249 cases of ovulation induction and/or previous abortions, whereas 198 gestations served as controls (no hCG administration).

Results

In the hCG treatment group, 43 ended in miscarriage (17.3%) versus 97 abortions in the control group (49%, P less than 0.01). In 160 cases of hMG/hCG generated gestations, 94 received hCG and 66 did not. The pregnancy wastage rates were 21.3% and 42.4%, respectively (P less than 0.05). In 144 cases of CC/hCG-induced pregnancies, 95 received hCG and 49 served as controls. The respective abortion rates were 15.8% and 44.8% (P less than 0.01). The remaining 143 spontaneous conceptions occurred in infertile patients with previous repeated abortions. In 60 of these conceptions, hCG was administered during the first 4 weeks of gestation and 83 cases served as control. The pregnancy wastage rates were 13.3% versus 56.6%, respectively (P less than 0.001).

Conclusion

Repetitive administration of hCG during the early gestation in cases that are at high risk of luteal inadequacy may significantly decrease the pregnancy wastage rate.

Read the guide

  • Miscarriage and Recurrent Pregnancy Loss: The Workup Most Women Never Get

    Miscarriage affects approximately 15% of clinically confirmed pregnancies. Recurrent pregnancy loss (RPL), defined as two or more clinical losses, affects 2 to 5% of couples. Most causes are diagnosable and treatable. This guide covers what the standard workup misses, what RRM-trained clinicians evaluate, and what outcomes look like after cause-based treatment.

    22 min read

Topics

By this author

Related research

Reproductive Endocrinology › Luteal Phase › Luteal Phase Deficiency · Pregnancy › Early Pregnancy › Miscarriage · Therapeutics › Hormonal Agents › Gonadotropins
Zeev Blumenfeld, Meir Ruach
Z Blumenfeld, M Ruach
PMID 1624004 1624004 DOI 10.1016/s0015-0282(16)55130-9 10.1016/s0015-0282(16)55130-9 Blumenfeld et al. 1992, Blumenfeld 1992